WeylChem to Expand US Capabilities

(c) David Burton/FuseGetty Images
(c) David Burton/FuseGetty Images

Custom manufacturing and toll services company WeylChem US will invest more than $13 million to expand production capabilities at its site in Elgin, South Carolina, USA. The company will also enhance the site’s infrastructure and existing equipment.

Work will start during the second quarter and should be completed by the end of 2017. WeylChem said the expansion was prompted by a new large and long-term customer tolling project. Rob Harpum, commercial director for the Americas, said the company’s goal is to be its partners’ first choice, both now and in the future.

The US arm is part of a platform of fine chemical companies owned by the International Chemical Investors Group (ICIG), which specializes in developing and producing products in partnership with companies from various industries, including agriculture, specialty chemicals, polymers and pharmaceuticals. The Pharmaceuticals activities are grouped under CordenPharma and chlorvinyls under Vynova.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.